We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+8.08%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$408B
AUM Growth
+$23B
Cap. Flow
+$1.73B
Cap. Flow %
0.42%
Top 10 Hldgs %
28.09%
Holding
14,143
New
3,278
Increased
5,446
Reduced
4,187
Closed
1,034

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$627M
2
BIDU icon
Baidu
BIDU
+$542M
3
MBB icon
iShares MBS ETF
MBB
+$492M
4
NVDA icon
NVIDIA
NVDA
+$429M
5
CMCSA icon
Comcast
CMCSA
+$421M

Sector Composition

Rank Sector Weight
1 Technology 3.73%
2 Healthcare 3.22%
3 Consumer Discretionary 2.4%
4 Financials 2.32%
5 Industrials 1.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBBP
12676
DELISTED
Strongbridge Biopharma plc.
SBBP
$59K ﹤0.01%
21,365
-4,613
-18% -$13.9K
NVIV
12677
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
$59K ﹤0.01%
+2,373
New +$71.1K
RNWK
12678
CALL
DELISTED
RealNetworks Inc
RNWK
$59K ﹤0.01%
13,900
-71,000
-84% -$248K
AWRE icon
12679
CALL
Aware
AWRE
$26M
$58K ﹤0.01%
+16,000
New +$68.2K
CXAIW icon
12680
CXApp Inc Warrant
CXAIW
$957K
$58K ﹤0.01%
+89,725
New +$109K
PBT
12681
Permian Basin Royalty Trust
PBT
$1.38B
$58K ﹤0.01%
+14,452
New +$57.6K
STG
12682
Sunlands Technology
STG
$44.1M
$58K ﹤0.01%
+4,231
New +$66.3K
TRAW icon
12683
Traws Pharma
TRAW
$6.85M
$58K ﹤0.01%
155
-1,362
-90% -$514K
CRKN
12684
DELISTED
Crown Electrokinetics Corp. Common Stock
CRKN
0
ACER
12685
CALL
DELISTED
Acer Therapeutics Inc
ACER
$58K ﹤0.01%
+18,600
New +$63.2K
ALUS
12686
DELISTED
Alussa Energy Acquisition Corp
ALUS
$58K ﹤0.01%
+5,770
New +$64.5K
CTIC
12687
CALL
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$58K ﹤0.01%
19,900
-56,800
-74% -$185K
BDSI
12688
PUT
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$58K ﹤0.01%
14,800
-1,300
-8% -$5.37K
DNK
12689
DELISTED
Phoenix Tree Holdings Limited American Depositary Shares, each representing ten (10) Class A ordinar
DNK
$58K ﹤0.01%
+24,379
New +$66.7K
AMBO
12690
Ambow Education Holding
AMBO
$5.66M
$57K ﹤0.01%
+2,610
New +$67K
CDTX
12691
DELISTED
Cidara Therapeutics
CDTX
$57K ﹤0.01%
+1,067
New +$52.7K
CYCN icon
12692
CALL
Cyclerion Therapeutics
CYCN
$14.9M
$57K ﹤0.01%
+1,020
New +$76.6K
INM icon
12693
InMed Pharmaceuticals
INM
$7.85M
$57K ﹤0.01%
+34
New +$72.9K
TEF
12694
PUT
DELISTED
Telefonica
TEF
$57K ﹤0.01%
14,182
+2,139
+18% +$8.71K
TTNP
12695
DELISTED
Titan Pharmaceuticals
TTNP
$57K ﹤0.01%
964
-162
-14% -$10.7K
XELB icon
12696
Xcel Brands
XELB
$7.27M
$57K ﹤0.01%
+2,873
New +$49.7K
NEX
12697
CALL
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$57K ﹤0.01%
15,400
-1,100
-7% -$4.45K
VOLT
12698
PUT
DELISTED
Volt Information Sciences, Inc.
VOLT
$57K ﹤0.01%
+14,500
New +$43K
HWCC
12699
DELISTED
Houston Wire & Cable Company
HWCC
$57K ﹤0.01%
10,969
-2,568
-19% -$9.84K
EMKR
12700
CALL
DELISTED
Emcore Corp
EMKR
$57K ﹤0.01%
+1,050
New +$63.3K

Similar funds

Citadel Advisors's Q1 2021 Portfolio in Review

As of Q1 2021, Citadel Advisors held 14,143 positions worth $408B, up 6% from $385B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q1 2021 filing shows 3,278 new, 5,446 increased, 4,187 reduced and 1,034 closed positions. Its largest new stake was SVB Financial Group: 445,853 shares worth $220M. The largest sale was iShares Core S&P 500 ETF, an estimated $1.29B.

By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3.7% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Citadel Advisors's largest Q1 2021 buy was SVB Financial Group: 445,853 shares worth $220M.
  • Citadel Advisors added most to Amazon in Q1 2021, an estimated $627M increase.
  • Citadel Advisors's biggest Q1 2021 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.29B.
  • Citadel Advisors fully exited iShares MSCI Emerging Markets ETF in Q1 2021, selling an estimated $321M.
  • Citadel Advisors's ten largest holdings make up 28% of its $408B portfolio in Q1 2021.
  • Citadel Advisors opened 3,278 new positions and closed 1,034 in Q1 2021.
  • Citadel Advisors's portfolio value rose 6% quarter-over-quarter to $408B.

Based on Citadel Advisors's 13F filing for Q1 2021, filed 17 May 2021.